Subtopic Deep Dive
Angiogenic Factors in Preeclampsia
Research Guide
What is Angiogenic Factors in Preeclampsia?
Angiogenic factors in preeclampsia refer to imbalances in circulating sFlt-1, PlGF, and VEGF levels that drive endothelial dysfunction and serve as diagnostic biomarkers for the disorder.
Research shows elevated sFlt-1 and reduced PlGF ratios predict adverse outcomes in suspected preeclampsia cases (Rana et al., 2012, 637 citations). Longitudinal studies link these factors to vascular changes before symptom onset (Noori et al., 2010, 351 citations). Over 10 key papers from 2008-2021 detail their roles in pathogenesis and clinical utility.
Why It Matters
Angiogenic factor ratios enable early risk stratification, reducing preterm delivery rates in high-risk pregnancies (Rana et al., 2012). They guide aspirin prophylaxis and timing of delivery, improving maternal and fetal outcomes (Rana et al., 2019, 1864 citations). Therapeutic modulation targeting sFlt-1 removal shows promise in pilot trials, addressing unmet needs in severe cases (Rana et al., 2020).
Key Research Challenges
Biomarker Assay Standardization
Variability in sFlt-1/PlGF ratio cutoffs across labs hinders clinical adoption (Rana et al., 2012). Studies report inconsistent thresholds for predicting adverse outcomes in diverse populations. Validation in multi-ethnic cohorts remains limited (Grill et al., 2009).
Temporal Dynamics Modeling
Changes in angiogenic factors precede clinical symptoms, but predictive models lack precision for early gestation (Noori et al., 2010). Longitudinal tracking reveals nonlinear trajectories tied to placental dysfunction (Fisher, 2015). Integrating with Doppler ultrasound improves accuracy but requires advanced analytics.
Therapeutic Pathway Targeting
Elevated sFlt-1 drives endothelial damage, yet safe inhibitors for pregnancy are undeveloped (Rana et al., 2020). Animal models show promise, but human trials face ethical barriers. Balancing fetal safety with maternal benefit poses ongoing hurdles.
Essential Papers
Preeclampsia
Sarosh Rana, Elizabeth Lemoine, Joey P. Granger et al. · 2019 · Circulation Research · 1.9K citations
Hypertensive disorders of pregnancy—chronic hypertension, gestational hypertension, and preeclampsia—are uniquely challenging as the pathology and its therapeutic management simultaneously affect m...
Angiogenic Factors and the Risk of Adverse Outcomes in Women With Suspected Preeclampsia
Sarosh Rana, Camille E. Powe, Saira Salahuddin et al. · 2012 · Circulation · 637 citations
Background— An imbalance in circulating angiogenic factors plays a central role in the pathogenesis of preeclampsia. Methods and Results— We prospectively studied 616 women who were evaluated for s...
Why is placentation abnormal in preeclampsia?
Susan J. Fisher · 2015 · American Journal of Obstetrics and Gynecology · 621 citations
FIGO (International Federation of Gynecology and Obstetrics) initiative on fetal growth: Best practice advice for screening, diagnosis, and management of fetal growth restriction
Nir Melamed, Ahmet Baschat, Yoav Yinon et al. · 2021 · International Journal of Gynecology & Obstetrics · 480 citations
Fetal growth restriction (FGR) is defined as the failure of the fetus to meet its growth potential due to a pathological factor, most commonly placental dysfunction. Worldwide, FGR is a leading cau...
Pre‐eclampsia‐like syndrome induced by severe COVID‐19: a prospective observational study
Manel Mendoza, Itziar García-Ruiz, Nerea Maíz et al. · 2020 · BJOG An International Journal of Obstetrics & Gynaecology · 367 citations
Objectives To investigate the incidence of clinical, ultrasonographic and biochemical findings related to pre‐eclampsia (PE) in pregnancies with COVID‐19, and to assess their accuracy to differenti...
Prospective Study of Placental Angiogenic Factors and Maternal Vascular Function Before and After Preeclampsia and Gestational Hypertension
Muna Noori, Ann E. Donald, Aspasia Angelakopoulou et al. · 2010 · Circulation · 351 citations
Background— Preeclampsia is a life-threatening pregnancy syndrome of uncertain origin. To elucidate the pathogenesis, we evaluated the temporal relationships between changes in vascular function an...
Effects of maternal obesity on placental function and fetal development
Kristy R. Howell, Theresa L. Powell · 2016 · Reproduction · 333 citations
Abstract Obesity has reached epidemic proportions, and pregnancies in obese mothers have increased risk for complications including gestational diabetes, hypertensive disorders, pre-term birth and ...
Reading Guide
Foundational Papers
Start with Rana et al. (2012, 637 citations) for prospective evidence on sFlt-1/PlGF predicting outcomes, then Noori et al. (2010, 351 citations) for vascular dynamics, and Grill et al. (2009) for biomarker review.
Recent Advances
Study Rana et al. (2019, 1864 citations) for comprehensive pathology, Rana et al. (2020, 280 citations) for pathophysiology updates, and Fisher (2015, 621 citations) for placentation links.
Core Methods
Core techniques include plasma ELISA for sFlt-1/PlGF ratios, longitudinal sampling pre- and post-onset, and ratio thresholds (>38 predicts adverse events) combined with uterine artery Doppler (Rana et al., 2012; Noori et al., 2010).
How PapersFlow Helps You Research Angiogenic Factors in Preeclampsia
Discover & Search
Research Agent uses searchPapers and exaSearch to find 50+ papers on sFlt-1/PlGF imbalances, then citationGraph maps connections from Rana et al. (2012, 637 citations) to recent works like Rana et al. (2020). findSimilarPapers expands to related biomarkers from the provided list.
Analyze & Verify
Analysis Agent applies readPaperContent to extract sFlt-1 ratio data from Rana et al. (2012), then runPythonAnalysis with pandas computes meta-analytic ratios across studies, verified by GRADE grading for evidence quality and verifyResponse (CoVe) for statistical consistency in predictive models.
Synthesize & Write
Synthesis Agent detects gaps in therapeutic modulation post-Rana et al. (2020), flags contradictions in biomarker thresholds, and uses exportMermaid for pathway diagrams; Writing Agent employs latexEditText, latexSyncCitations for Rana et al. papers, and latexCompile for review manuscripts.
Use Cases
"Analyze sFlt-1/PlGF ratios from longitudinal preeclampsia studies using Python."
Research Agent → searchPapers → Analysis Agent → readPaperContent (Rana 2012, Noori 2010) → runPythonAnalysis (pandas meta-analysis of ratios, matplotlib plots) → researcher gets CSV of stratified risks and GRADE-scored evidence.
"Draft a review on angiogenic factors with citations and figures."
Synthesis Agent → gap detection → Writing Agent → latexEditText (intro on imbalances) → latexSyncCitations (Rana 2019 et al.) → latexCompile + exportMermaid (VEGF pathway diagram) → researcher gets compiled LaTeX PDF.
"Find code for modeling angiogenic factor dynamics in preeclampsia."
Research Agent → paperExtractUrls (Noori 2010) → Code Discovery → paperFindGithubRepo → githubRepoInspect → researcher gets validated simulation scripts for sFlt-1 trajectories.
Automated Workflows
Deep Research workflow conducts systematic review of 50+ angiogenic papers: searchPapers → citationGraph (centered on Rana 2019) → structured report with GRADE tables. DeepScan applies 7-step analysis to verify sFlt-1 data from Rana 2012 with CoVe checkpoints and runPythonAnalysis. Theorizer generates hypotheses on PlGF modulation from literature patterns in Fisher 2015 and Rana 2020.
Frequently Asked Questions
What defines angiogenic factors in preeclampsia?
Imbalances feature high sFlt-1 inhibiting VEGF/PlGF, causing endothelial dysfunction (Rana et al., 2019).
What are key methods for measuring these factors?
ELISA assays quantify plasma sFlt-1/PlGF ratios; automated platforms standardize results for clinical use (Rana et al., 2012).
What are the most cited papers?
Rana et al. (2019, Circulation Research, 1864 citations) reviews pathology; Rana et al. (2012, Circulation, 637 citations) links ratios to outcomes.
What open problems exist?
Developing pregnancy-safe sFlt-1 inhibitors and standardizing ratios across populations remain unsolved (Rana et al., 2020).
Research Pregnancy and preeclampsia studies with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Angiogenic Factors in Preeclampsia with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers